Omomyc expression in skin prevents Myc-induced papillomatosis

Cell Death and Differentiation

Volumn 11, Issue 9, 2004, Pages 1038-1045

  Soucek, L ^a,b   Nasi, S ^b   Evan, G I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Apoptosis; Bcl xL; Myc; Omomyc; p53

Indexed keywords

4 HYDROXYTAMOXIFEN; ALCOHOL; LEUCINE ZIPPER PROTEIN; MYC PROTEIN; MYCER; OMOMYC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL CELL; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; E BOX ELEMENT; EPIDERMIS; EPIDERMIS HYPERPLASIA; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SENSITIZATION; SKIN CANCER; SKIN PAPILLOMA; TISSUE CULTURE CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPIDERMIS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; HYDROXYTESTOSTERONES; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; PAPILLOMA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RATS; SKIN; SKIN NEOPLASMS; TIME FACTORS; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 4544221109     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401443     Document Type: Article

References (24)

1. Eisenman RN (2001) Deconstructing myc. Genes Dev. 15: 2023-2030
2. Lutz W, Leon J and Eilers M (2002) Contributions of Myc to tumorigenesis. Biochim. Biophys. Acta. 1602: 61-71
3. Mateyak MK, Obaya AJ, Adachi S and Sedivy JM (1997) Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8: 1039-1048
4. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR and Bishop JM (2001) c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414: 768-773
5. Evan G and Littlewood T (1998) A matter of life and cell death. Science 281: 1317-1322
6. Askew DS, Ashmun RA, Simmons BC and Cleveland JL (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922
7. Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G and Nasi S (1998) Design and properties of a Myc derivative that efficiently homodimerizes. Oncogene 17: 2463-2472
8. Soucek L, Jucker R, Panacchia L, Ricordy R, Tato F and Nasi S (2002) Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. Cancer Res. 62: 3507-3510
9. Juin P, Hueber AO, Littlewood T and Evan G (1999) c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13: 1367-1381
10. Sherr CJ (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12: 2984-2991
11. Pelengaris S, Littlewood T, Khan M, Elia G and Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell. 3: 565-577
12. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 275: 1132-1136
13. Klefstrom J, Verschuren EW and Evan G (2002) c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway. J. Biol. Chem. 277: 43224-43232
14. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12: 2424-2433
15. Carroll JM, Albers KM, Garlick JA, Harrington R and Taichman LB (1993) Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc. Natl. Acad. Sci. USA 90: 10270-10274
16. Johnson LD, Idler WW, Zhou XM, Roop DR and Steinert PM (1985) Structure of a gene for the human epidermal 67-kDa keratin. Proc. Natl. Acad. Sci. USA 82: 1896-1900
17. Nelson WG and Sun TT (1983) The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J. Cell Biol. 97: 244-251
18. Gandarillas A, Goldsmith LA, Gschmeissner S, Leigh IM and Watt FM (1999) Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp. Dermatol. 8: 71-79
19. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD and Gerdes J (1993) The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123: 513-522
20. Lindstrom M and Wiman K (2002) Role of genetic and epigenetic changes in Burkitt lymphoma. Semin. Cancer Biol. 12: 381
21. Cory S, Vaux DL, Strasser A, Harris AW and Adams JM (1999) Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 59: 1685s-1692s
22. Evan GI and Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348
23. Pelengaris S, Khan M and Evan GI (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109: 321-334
24. Leigh I and Watt F (1994) Keratinocyte Methods. (Cambridge: University Press) pp. 25-31